Expertise in
11
conditions

Maria A. Buti

Hepatology
Barcelona, CT, ES 
Expertise in
11
conditions
Barcelona, CT, ES 

Overview

Maria Buti is a Hepatologist practicing medicine in Barcelona, Spain.

Ms. Buti is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Hepatitis, Hepatitis B, Hepatitis D, Hepatitis C, and Liver Transplant.

She is actively involved in clinical research, co-authoring 465 peer reviewed articles and participating in 3 clinical trials.

Specialties

Hepatology

Gender

Female

Locations

Barcelona, CT, Spain
Other Locations
Bellaterra, CT 08193, Spain
Madrid, MD, Spain
Spain
Cerdanyola Del Valles, CT 08193, Spain
Lleida, CT, Spain
Granada, AN, Spain
Valle, AS, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase IIb Multi-Center, Randomised, Open Label Study to Assess the Efficacy and Safety of Sequential Treatment With GSK3228836 Followed by Pegylated Interferon Alpha 2a in Participants With Chronic Hepatitis B Virus (B-Together)
A Phase IIb Multi-Center, Randomised, Open Label Study to Assess the Efficacy and Safety of Sequential Treatment With GSK3228836 Followed by Pegylated Interferon Alpha 2a in Participants With Chronic Hepatitis B Virus (B-Together)
Enrollment Status: Completed
Publish Date: May 02, 2024
Intervention Type: Drug
Study Drugs: GSK3228836, PegIFN, NA therapy
Study Phase: Phase 2
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Enrollment Status: Unknown
Publish Date: August 25, 2023
Intervention Type: Drug
Study Drug: Peginterferon Lambda-1a
Study Phase: Phase 3
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drugs: GSK3228836, Nucleos(t)ide therapy
Study Phase: Phase 2
View 2 Less Clinical Trials

465 Total Publications

Corrigendum to 'Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort' [JHEP Reports (2026) 19;8(8):101898].
Corrigendum to 'Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort' [JHEP Reports (2026) 19;8(8):101898].
Journal: JHEP reports : innovation in hepatology
Published: September 03, 2026

Frequently Asked Questions about Maria A. Buti

Is Maria A. Buti a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Maria A. Buti is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Maria A. Buti specialize in?

While Maria A. Buti is a Hepatology, they have specific expertise in Hepatitis, Hepatitis B, and Hepatitis D. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hepatology.

Does Maria A. Buti participate in research or clinical trials?

Yes. Maria A. Buti has published 465 articles and abstracts on conditions like Hepatitis. You can view a list of Maria A. Buti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Buti's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile